Wednesday, 28 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Share Pledge

Bliss GVS Pharma Share Pledge

Bliss GVS Pharma's promoters pledged 5,09,84,595 equity shares (47.95%) in favour of Catalyst Trusteeship as Debenture Trustee on 30 Sep 2026. No loan or consideration amount is disclosed in the filing.

Source

BSE filing, NSE: BLISSGVS. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Bliss GVS Pharma Ltd: key numbers

Share price
₹652.75
Market cap
₹6,944 Cr
Revenue (annual)
₹927.1 Cr
Net profit (annual)
₹129.1 Cr
P/E (TTM)
51.0×Sector 46.5×
Promoter holding
50.07%+15.06% QoQ
FII holding
5.03%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Bliss GVS Pharma Ltd

All →

Other share pledge announcements

All →